Gilead Sciences (NASDAQ:GILD) just recently announced that it will start paying a quarterly dividend of 43 cents per share. This equals to a 1.76% yield, which may not be as high as most dividend investors would like to see, but I believe this announcement provides a compelling opportunity. The company has a market cap greater than $140 billion, which means that many institutional funds are already holding its stock. The announcement of its dividend will mean that those funds with dividend requirements will be able to purchase shares of the company. This will help support the share price as there is an increase in buyers. Read more